✓ Early-stage friendly

Research approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications 2027 Grant

••••• organisation

An organisation

Summary

This is a European research-funding programme supporting approaches to reduce adverse drug reactions from polypharmacy, using pharmacogenomics, AI, and health data. It is not a climate or sustainability grant and falls outside the scope of this classification system.

Summary by Raise Lens from the official notice · 8 Jun 2026Accurate?

About this grant

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Unlock the funder, link and full detail

Create a free account to unlock 3 full listings a month, including the funder name, the application link and the complete programme detail.

Create free account →See Pro

Frequently asked questions

How much funding does this grant offer?: Research approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications offers Up to €38M.
When is the Research approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications deadline?: Applications close 13 Apr 2027 (213 days left).
Who can apply for Research approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications?: Eligibility covers organisations in EU; university, research-institution, nonprofit, large-company, consortium. The full eligibility conditions are part of the Pro detail.